DRAFT AGENDA

PEDIATRIC ADVISORY SUBCOMMITTEE MEETING

CURRENT EPIDEMIOLOGY AND THERAPEUTIC INTERVENTIONS RELEVANT TO HYPERBILIRUBINEMIA IN THE TERM AND NEAR-TERM NEWBORN

Day #1 – June 11, 2003

8:30 Welcome and Overview of the Day Dianne Murphy, M.D.

Director, Office of Pediatric Therapeutics

8:50 Diagnosing and Managing Hyperbilirubinemia Tom Newman, M.D., M.P.H.

UCSF School of Medicine

9:35 AHRQ Report Stanley Ip, M.D.

Tufts New England Medical Center

Joseph Lau, M.D.

Tufts New England Medical Center

Rebecca O’Brien, M.D.

Tufts New England Medical Center

10:20 Discussion of Presentations

10:30 Break

10:45 Question 1

11:00 Phototherapy William Oh, M.D.

Brown University

11:45 Outpatient Phototherapy Connie Schomann, R.N.

12:00 Lunch

1:00 A Parent’s Perspective Sue Sheridan, President

Parents of Infants and Children

with Kernicterus

1:20 Kernicterus Surveillance Marshallyn Yeargin-Allsop, M.D.

Centers for Disease Control and Prevention

1:40 Metalloporphyrin Heme Oxygenase Inhibitors David Stevenson, M.D.

Stanford University

2:25 Break

2:40 Open Public Hearing

3:40 Question 2

4:00 Ethical Issues Skip Nelson, M.D., Ph.D.

The Children’s Hospital of Philadelphia

4:30 Question 3 & 4

4:50 Chair/Committee Final Comments

5:00 Adjourn for the Day